- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06140043
Augmented Reality for Orthognatic Surgery Patient Education (NARRATE)
March 12, 2024 updated by: University Medical Center Groningen
To evaluate whether the use of augmented reality (AR) for visualizing 3D models can be a valuable addition to patient education regarding orthognathic procedures compared to using only 2D visualization (on a computer screen).
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
60
Phase
- Phase 2
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: S Tabernée Heijtmeijer, MSc.
- Phone Number: (050) 361 0213|
- Email: s.j.c.tabernee.heijtmeijer@umcg.nl
Study Locations
-
-
-
Aachen, Germany
- Recruiting
- Uniklinik RWTH Aachen
-
Contact:
- Behrus Puladi
- Email: bpuladi@ukaachen.de
-
Sub-Investigator:
- Ashkan Rashad
-
Sub-Investigator:
- Oliver-Costin Vladu
-
-
-
-
-
Groningen, Netherlands
- Recruiting
- UMC Groningen
-
Contact:
- S Tabernée Heijtmeijer, MSc.
- Email: s.j.c.tabernee.heijtmeijer@umcg.nl
-
Principal Investigator:
- Joep Kraeima, dr.
-
Utrecht, Netherlands
- Recruiting
- UMC Utrecht
-
Contact:
- N Janssen, dr.
- Email: n.g.janssen-2@umcutrecht.nl
-
Sub-Investigator:
- Noa Nicolai
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patients planned for an orthognathic intake consult in the period of July to april 2024 at the UMCU or UMCG or Uniklinik RTWH Aachen;
- Patients with dentofacial deformity (dysgnathia) including: class II malocclusion, class III malocclusion, or open bite;
- Patients undergoing treatment using BSSO (Bilateral Sagittal Split Osteotomy), Le Fort I, or BIMAX;
- The planned treatment is either with or without a genioplasty procedures.
- Patients 16 years of age or older.
Exclusion Criteria:
- Patients with craniofacial syndromes, such as cleft lip and palate
- Patient which require an osteotomy involving two or more segments
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: 2D Monitor screen
Patient consultation with 3D models of bone and skin, seen with a monitor screen
|
Providing information about the current clinical problem of orthognatic surgery patients and the proposed treatment for it.
|
Experimental: 3D AR
Patient consultation with 3D models of bone and skin, seen in augmented reality trough AR glasses
|
Providing information about the current clinical problem of orthognatic surgery patients and the proposed treatment for it.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient satisfaction
Time Frame: Immediately after the regular first intake consult
|
Patient satisfaction of the intake consult.
Focussed on the explanation of the condition and proposed treatment, measured through a questionnaire.
The questionnaire measures the clarity and importance of the information for the patient.
For both parameters a median score will be calculated between 0 and 5
|
Immediately after the regular first intake consult
|
Objective knowledge
Time Frame: Immediately after the regular first intake consult
|
Patient knowledge of the medical problem and proposed treatment, also measured by a questionnaire.
Patient can get 2 points when all four question are right, if all questions are answered incorrectly, then -2 points
|
Immediately after the regular first intake consult
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Diagnosis
Time Frame: During the first intake consult
|
Orthognatic diagnosis
|
During the first intake consult
|
Occlusion Class
Time Frame: During the first intake consult
|
Class of the occlusion of the patient before surgery
|
During the first intake consult
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: J Kraeima, dr., UMC Groningen
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2023
Primary Completion (Estimated)
April 30, 2024
Study Completion (Estimated)
June 1, 2024
Study Registration Dates
First Submitted
October 25, 2023
First Submitted That Met QC Criteria
November 16, 2023
First Posted (Actual)
November 18, 2023
Study Record Updates
Last Update Posted (Actual)
March 15, 2024
Last Update Submitted That Met QC Criteria
March 12, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 17618
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Malocclusion
-
mahmoud abdelhameed mohamedCompleted
-
Al-Azhar UniversityCompleted3D Evaluation of Powerscope Appliance in Treatment of Skeletal Class 2 Malocclusion (Powerscope app)Class II Malocclusion, Division 1Egypt
-
Al-Azhar UniversityCompletedClass II Malocclusion, Division 1Egypt
-
Ain Shams UniversityCompletedClass II Malocclusion Division 1Egypt
-
Cairo UniversityUnknownClass II Malocclusion, Division 1
-
University of BaghdadRecruitingTreating Class II Malocclusion and Bimaxillary ProclinationIraq
-
Damascus UniversityCompletedClass II Malocclusion, Division 1Syrian Arab Republic
-
Al-Azhar UniversityRecruiting
-
University of AlbertaRecruiting
-
Future University in EgyptCompleted
Clinical Trials on Patient consultation
-
Vejle HospitalThe Ottawa Hospital Research InstituteRecruiting
-
University Hospital, GrenobleCompletedGastroenteritis | PharyngitisFrance
-
Thomas Jefferson UniversityNational Cancer Institute (NCI)CompletedStage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Clinical Stage III Gastric Cancer AJCC v8 | Clinical Stage IV Gastric Cancer AJCC v8 | Stage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer... and other conditionsUnited States
-
Philipps University Marburg Medical CenterUnknownHealthy ParticipantsGermany
-
Centre Hospitalier Universitaire, AmiensCompleted
-
University of Southern DenmarkVejle Hospital; Region of Southern Denmark; Odense Patient Data Explorative Network and other collaboratorsCompleted
-
Health Science Center of Xi'an Jiaotong UniversityPakistan Institute of Medical Sciences Islamabad Pakistan; District Headquarter...UnknownPatient Satisfaction | TB - TuberculosisPakistan
-
Vejle HospitalUniversity of Southern Denmark; Danish Breast Cancer Cooperative Group; Danish...CompletedBreast Neoplasms | Shared Decision Making | Radiotherapy, AdjuvantDenmark
-
University of Maryland, BaltimoreCompleted
-
Hospices Civils de LyonCompletedChemotherapy Effect | G-CHOP Chemotherapy | R-CHOP ChemotherapyFrance